Alev Özer
Kahramanmaraş Sütçü İmam University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alev Özer.
Journal of Obstetrics and Gynaecology Research | 2010
Alev Özer; Gulnur Ozaksıt; Mine Kanat-Pektas; Serdar Ozer
Aim: The present study aims to assign the reference values for nasal bone length (NBL) screened at 11–14 weeks of pregnancy in the Turkish population, determining whether the NBLs specified for Caucasians can be validated for Turkish people.
International Journal of Gynecology & Obstetrics | 2016
Önder Ercan; Alev Özer; Bülent Köstü; Murat Bakacak; Gurkan Kiran; Fazıl Avcı
To compare vaginal length and sexual function after total laparoscopic hysterectomy (TLH), total abdominal hysterectomy (TAH), and vaginal hysterectomy (VH).
Journal of Obstetrics and Gynaecology Research | 2016
Alev Özer; Serdar Ozer; Mine Kanat-Pektas
The present study aims to determine how transvaginal ultrasonography and histopathological examination findings are correlated in a cohort of premenopausal and postmenopausal Turkish women with abnormal uterine bleeding.
Journal of Maternal-fetal & Neonatal Medicine | 2015
Önder Ercan; Bülent Köstü; Alev Özer; Salih Serin; Murat Bakacak
Abstract Objective: The efficacy and safety were assessed of a misoprostol regimen used alone or in combination with foley catheter for second trimester pregnancy termination. Methods: A retrospective examination was made of the records of patients who underwent pregnancy termination at 14–24 weeks of gestation in our university hospital between January 2011 and June 2014. Records were available for patients 378 who underwent terminations. Group 1 comprised patients with no history of cesarean section. An initial dose of 200 μg misoprostol was administered intravaginally and then until the termination was completed an additional 200 μgr dose was administered sublingually every 4 hours (Group 1: 234 patients). Group 2 comprised patients with a history of cesarean section. An initial dose of 200 μg misoprostol was administered intravaginally and 2 hours later an intracervical foley catheter was inserted (Group 2: 144 patients). Results: The total misoprostol dosage used was 1160 μg and 560 μg (p< 0.001), intervals from the administration of the first misoprostol tablet until termination were 854.8 and 704.2 minutes (p= 0.03) in Groups 1 and 2, respectively. Conclusions: The misoprostol + foley catheter combination reduces the total dosage of misoprostol required for termination and shortens the termination interval, thereby increasing patient’s comfort. Based on these results, the usage of the misoprostol + foley catheter combination can be recommended especially for patients with a history of caesarian section.
Medical Science Monitor | 2017
Alev Özer; Bülent Köstü
Background This study aimed to determine the effects of use of a local hemostatic gelatin sponge (GS) on postoperative morbidity in patients undergoing cesarean section (CS). Material/Methods The records of 318 patients who underwent CS surgery were retrospectively evaluated. Group 1 consisted of 59 patients with gelatin sponge (GS) applied, and Group 2 consisted of 259 patients with no GS applied. The groups were compared for time to the first flatus, nausea and vomiting, requirement for anti-emetic drugs, development of postoperative ileus, and the length of hospitalization. Results The patients in Group 1 and Group 2 were statistically similar in mean age, gravida, parity, and body mass index (BMI) (p=0.352, p=0.275, p=0.458, and p=0.814, respectively). No significant difference was determined in the number of patients with nausea, vomiting, anti-emetic drug use, febrile morbidity, and postoperative ileus (p=0.063, p=0.436, p=328, p=0.632, and p=0.179, respectively). Time to the first flatus and length of hospitalization were significantly longer in Group 2 (p<0.001 and p<0.001, respectively). Conclusions Delay in recovery of bowel motility may be due to the local hypersensitivity reaction caused by GS and/or dislocation of this local hemostat. Women who receive gelatin sponge treatment during CS should be monitored closely for the recovery of postoperative intestinal motility.
International Journal of Gynecology & Obstetrics | 2017
Safak Hatirnaz; Alev Özer; Ebru Hatirnaz; Melahat Atasever; Serdar Başaranoğlu; Mine Kanat-Pektas; Murat Api
To determine the efficiency of pre‐implantation genetic screening (PGS) among women scheduled to undergo intracytoplasmic sperm injection who had experienced recurrent in vitro fertilization (IVF) failure.
Archives of Gynecology and Obstetrics | 2009
Alev Özer; Mine Kanat-Pektas; Serdar Ozer; Omer L. Tapisiz; Ebru Zulfikaroglu; Nuri Danisman
Archives of Gynecology and Obstetrics | 2010
Mehmet Albayrak; Alev Özer; Omer Demir; Serdar Ozer; Salim Erkaya
Fertility and Sterility | 2016
M.H. Dahan; Ebru Hatirnaz; S.L. Tan; Baris Ata; Alev Özer; Mine Kanat-Pektas; Safak Hatirnaz
Journal of Clinical and Experimental Investigations | 2018
Alev Özer; Abdullah Tok; Bülent Köstü